(Q46755981)

24 December 2017

title

Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease (English)

1 reference

24 December 2017

1 reference

S A Eshuis

1

1 reference

24 December 2017

R P Maguire

2

1 reference

24 December 2017

K L Leenders

3

1 reference

24 December 2017

S Jonkman

4

1 reference

24 December 2017

P L Jager

5

1 reference

24 December 2017

publication date

15 October 2005

1 reference

24 December 2017

number of pages

10

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

24 December 2017

volume

33

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

200-209

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-005-1904-y

exact match

0 references

cites work

A clinicopathologic study of 100 cases of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1904-Y

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1904-Y

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1904-Y

[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1904-Y

Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease

21 January 2018

1 reference

12 December 2020

Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography

1 reference

12 December 2020

Dopamine transporters decrease with age.

1 reference

12 December 2020

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

1 reference

12 December 2020

SPECT and PET imaging of the dopaminergic system in Parkinson's disease

1 reference

12 December 2020

Multimodal image coregistration and partitioning--a unified framework.

1 reference

12 December 2020

1 reference

12 December 2020

Brain dopamine transporter: gender differences and effect of chronic haloperidol.

1 reference

12 December 2020

Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.

1 reference

12 December 2020

Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.

1 reference

12 December 2020

Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo

1 reference

12 December 2020

Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach.

1 reference

12 December 2020

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease

1 reference

12 December 2020

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

1 reference

12 December 2020

Fluorine-18-FPCT: a PET radiotracer for imaging dopamine transporters.

1 reference

12 December 2020

One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT.

1 reference

12 December 2020

[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease

1 reference

12 December 2020

Striatal 18F-dopa uptake: absence of an aging effect

1 reference

12 December 2020

Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers

1 reference

12 December 2020

Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease

1 reference

12 December 2020

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group

1 reference

12 December 2020

1 reference

12 December 2020

Measuring the rate of progression of Parkinson's disease over a 5-year period with beta-CIT SPECT.

1 reference

12 December 2020

Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.

1 reference

12 December 2020

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

1 reference

12 December 2020

Striatal function in normal aging: implications for Parkinson's disease.

1 reference

12 December 2020

Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography.

1 reference

12 December 2020

Dopamine transporter imaging with fluorine-18-FPCIT and PET.

1 reference

12 December 2020

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

1 reference

12 December 2020

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

1 reference

12 December 2020

Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies?

1 reference

12 December 2020

Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.

1 reference

12 December 2020

Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.

1 reference

12 December 2020

[123I]beta-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls.

1 reference

12 December 2020

Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models

1 reference

12 December 2020

Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects

1 reference

12 December 2020

Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?

1 reference

12 December 2020

10.1007/S00259-005-1904-Y

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017